Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

MGTX

MeiraGTx Holdings plc

Last Close
May 03 • 04:00PM ET
5.00
Dollar change
+0.01
Percentage change
0.20 		%
Held by: IWM IBB IWO VHT VTWO IWN IWC DFAS AVSC VTWG Scroll to Statements
IndexRUT P/E- EPS (ttm)-1.58 Insider Own22.88% Shs Outstand63.60M Perf Week4.17%
Market Cap321.55M Forward P/E3.38 EPS next Y1.48 Insider Trans0.00% Shs Float49.59M Perf Month-9.26%
Income-84.03M PEG- EPS next Q-0.51 Inst Own50.72% Short Float2.29% Perf Quarter-15.40%
Sales14.02M P/S22.94 EPS this Y-19.30% Inst Trans-1.93% Short Ratio7.62 Perf Half Y-0.79%
Book/sh2.17 P/B2.30 EPS next Y183.26% ROA- Short Interest1.14M Perf Year-14.38%
Cash/sh2.01 P/C2.48 EPS next 5Y2.40% ROE- 52W Range3.49 - 8.35 Perf YTD-28.77%
Dividend Est.- P/FCF- EPS past 5Y19.75% ROI-37.64% 52W High-40.12% Beta1.42
Dividend TTM- Quick Ratio2.38 Sales past 5Y17.92% Gross Margin2.05% 52W Low43.27% ATR (14)0.26
Dividend Ex-Date- Current Ratio2.38 EPS Y/Y TTM36.99% Oper. Margin-977.82% RSI (14)39.45 Volatility4.78% 4.65%
Employees425 Debt/Eq0.65 Sales Y/Y TTM- Profit Margin-599.46% Recom1.00 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq0.62 EPS Q/Q138.09% Payout- Rel Volume0.53 Prev Close4.99
Sales Surprise-68.81% EPS Surprise1500.00% Sales Q/Q-57.64% EarningsMar 14 BMO Avg Volume149.27K Price5.00
SMA20-3.86% SMA50-12.89% SMA200-11.59% Trades Volume78,548 Change0.20%
Date Action Analyst Rating Change Price Target Change
Oct-23-20Initiated RBC Capital Mkts Outperform $27
Sep-15-20Resumed BofA Securities Buy $20
Sep-03-19Initiated Piper Jaffray Overweight $40
Feb-27-19Reiterated Chardan Capital Markets Buy $30 → $40
Jul-03-18Initiated BofA/Merrill Buy
Jul-03-18Initiated Barclays Overweight
Apr-24-24 04:30PM
MeiraGTx to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Apr-18-24 04:30PM
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
(GlobeNewswire)
Mar-14-24 10:31AM
MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023
(GuruFocus.com) -7.09%
09:45AM
MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates
(Zacks)
08:30AM
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
(GlobeNewswire)
08:00AM Loading…
Feb-13-24 08:00AM
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
(GlobeNewswire) -9.55%
Feb-01-24 07:30AM
Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors
(PR Newswire)
Jan-10-24 09:55AM
Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet
(Zacks)
08:49AM
MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions
(Zacks)
Jan-02-24 12:17PM
MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why
(Zacks)
Dec-25-23 09:55AM
Wall Street Analysts Believe MeiraGTx Holdings PLC (MGTX) Could Rally 221.78%: Here's is How to Trade
(Zacks)
Dec-21-23 07:07AM
J&J bets bigger on MeiraGTxs eye gene therapy
(BioPharma Dive) +32.59%
07:00AM
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
(GlobeNewswire)
Nov-21-23 04:30PM
MeiraGTx to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Nov-14-23 07:21PM
MeiraGTx Holdings PLC Reports Q3 2023 Financial Results and Operational Progress
(GuruFocus.com)
08:00AM Loading…
08:00AM
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
(GlobeNewswire)
Oct-31-23 08:00AM
BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions
(News Direct)
Oct-30-23 08:25AM
Sanofi invests in MeiraGTx and its gene-regulating technology
(BioPharma Dive) +20.27%
07:30AM
MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities
(GlobeNewswire)
Oct-24-23 08:30AM
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
(GlobeNewswire)
Aug-10-23 09:15AM
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Misses Revenue Estimates
(Zacks)
08:00AM
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
(GlobeNewswire)
Aug-01-23 09:10AM
MeiraGTx Announces Poster Presentation at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-Oncology
(GlobeNewswire)
Jul-19-23 08:30AM
MeiraGTx Announces its Wholly-Owned Gene Therapy Manufacturing Facility in Shannon, Ireland has Received Commercial MIA Authorization for QC Testing
(GlobeNewswire) +8.04%
Jun-28-23 07:53PM
MeiraGTx Holdings PLC (MGTX) Soars 8.2%: Is Further Upside Left in the Stock?
(Zacks) +8.20%
Jun-27-23 03:41PM
MeiraGTx's Investigational Drug Shows Improved Symptoms In Radiation-Induced Oral Dryness
(Benzinga) -7.31%
07:30AM
MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
(GlobeNewswire)
Jun-22-23 04:01PM
MeiraGTx to Present 12-month Data from All Cohorts of the Completed Phase 1 AQUAx Clinical Study and an Update on the Companys Recently Initiated Phase 2 Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Tuesday, June 27, 2023
(GlobeNewswire)
Jun-16-23 10:00AM
MeiraGTx Holdings (NASDAQ:MGTX) shareholders have endured a 43% loss from investing in the stock three years ago
(Simply Wall St.)
Jun-02-23 09:55AM
Does MeiraGTx Holdings PLC (MGTX) Have the Potential to Rally 320.9% as Wall Street Analysts Expect?
(Zacks) +9.29%
09:55AM Loading…
May-17-23 09:55AM
Wall Street Analysts Predict a 314.29% Upside in MeiraGTx Holdings PLC (MGTX): Here's What You Should Know
(Zacks) +10.00%
May-16-23 09:00AM
MeiraGTx Announces the Presentation of Nine Posters at the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting
(GlobeNewswire) +13.82%
May-11-23 08:00AM
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
(GlobeNewswire) -5.97%
May-03-23 08:30AM
MeiraGTx Announces $60 Million Private Placement of Ordinary Shares
(GlobeNewswire) +12.52%
Apr-21-23 08:30AM
MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
(GlobeNewswire)
Apr-20-23 05:00PM
MeiraGTx to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Apr-12-23 11:41AM
MeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake
(Simply Wall St.)
Mar-16-23 06:06AM
A Look At The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)
(Simply Wall St.)
Mar-14-23 08:00AM
MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results
(GlobeNewswire)
Feb-13-23 03:00AM
JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics.
(Barrons.com) +7.74%
Dec-13-22 01:56PM
MeiraGTx's Investigational Candidate Shows Improvement In Radiation Induced Dry Mouth Symptoms
(Benzinga)
07:30AM
MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
(GlobeNewswire)
06:26AM
MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 71% if they invested three years ago
(Simply Wall St.)
Dec-08-22 04:30PM
MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022
(GlobeNewswire)
Nov-22-22 04:30PM
MeiraGTx to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Nov-16-22 06:02AM
MeiraGTx Holdings Third Quarter 2022 Earnings: Misses Expectations
(Simply Wall St.)
Nov-11-22 10:02AM
Time To Worry? Analysts Are Downgrading Their MeiraGTx Holdings plc (NASDAQ:MGTX) Outlook
(Simply Wall St.)
Nov-10-22 09:25AM
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates
(Zacks)
08:00AM
MeiraGTx Reports Third Quarter 2022 Financial and Operational Results and Receives $25 Million Investment from Johnson & Johnson Innovation - JJDC, Inc.
(GlobeNewswire)
Nov-03-22 10:48AM
Institutional investors own a significant stake of 35% in MeiraGTx Holdings plc (NASDAQ:MGTX)
(Simply Wall St.)
Oct-04-22 08:00AM
MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress
(GlobeNewswire) +9.25%
Oct-01-22 10:00AM
Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of Investigational Gene Therapy Botaretigene Sparoparvovec (AAV-RPGR) and Sustained Vision Improvement in Patients with X-Linked Retinitis Pigmentosa (XLRP)
(GlobeNewswire)
Sep-16-22 02:00AM
MeiraGTxs Industry-Leading Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Head of Irish Government
(GlobeNewswire)
Sep-08-22 04:30PM
MeiraGTx to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-11-22 09:45AM
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates
(Zacks) +6.71%
08:30AM
MeiraGTx Reports Second Quarter 2022 Financial and Operational Results
(GlobeNewswire)
Aug-03-22 08:00AM
MeiraGTx Announces Financing Agreement with Perceptive Advisors for Up to $100 Million Secured by Manufacturing Facilities
(GlobeNewswire) +19.72%
Jun-28-22 02:28PM
MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial
(Benzinga)
07:00AM
MeiraGTx Announces Positive Top-Line Data from the MGT009 Phase 1/2 Clinical Study Demonstrating Safety and Improvement in Multiple Domains of Vision in X-Linked Retinitis Pigmentosa Patients treated with Botaretigene Sparoparvovec (AAV-RPGR) compared to Untreated Randomized Control
(GlobeNewswire)
Jun-16-22 06:39AM
Further weakness as MeiraGTx Holdings (NASDAQ:MGTX) drops 13% this week, taking three-year losses to 67%
(Simply Wall St.)
May-30-22 08:32PM
Down More Than 40%: Analysts Say These 2 Beaten-Down Stocks Are Oversold
(TipRanks)
May-12-22 09:15AM
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
(Zacks)
08:00AM
MeiraGTx Reports First Quarter 2022 Financial and Operational Results
(GlobeNewswire)
May-10-22 03:46PM
Companies Like MeiraGTx Holdings (NASDAQ:MGTX) Are In A Position To Invest In Growth
(Simply Wall St.) +7.48%
May-09-22 05:35PM
Krystal Biotech, Inc. (KRYS) Reports Q1 Loss, Lags Revenue Estimates
(Zacks) -8.22%
May-05-22 06:15PM
Gritstone bio Inc. (GRTS) Reports Q1 Loss, Lags Revenue Estimates
(Zacks) -7.11%
May-04-22 04:01PM
MeiraGTx Presents Clinical Data on Botaretigene Sparoparvovec for the Treatment of X-Linked Retinitis Pigmentosa at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
(GlobeNewswire)
08:15AM
Horizon Therapeutics (HZNP) Q1 Earnings and Revenues Beat Estimates
(Zacks)
Apr-27-22 08:00AM
MeiraGTx Appoints Debra Yu, MD to Board of Directors
(GlobeNewswire)
Apr-19-22 04:30PM
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
(GlobeNewswire)
Mar-30-22 06:46AM
MeiraGTx Holdings PLC (MGTX) Stock Jumps 6.5%: Will It Continue to Soar?
(Zacks)
Mar-15-22 02:30PM
Need To Know: Analysts Are Much More Bullish On MeiraGTx Holdings plc (NASDAQ:MGTX) Revenues
(Simply Wall St.)
Mar-10-22 09:25AM
MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Tops Revenue Estimates
(Zacks)
08:00AM
MeiraGTx Reports Fourth Quarter and Full Year 2021 Financial and Operational Results
(GlobeNewswire)
Mar-08-22 05:35PM
Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates
(Zacks)
05:07AM
What Type Of Shareholders Make Up MeiraGTx Holdings plc's (NASDAQ:MGTX) Share Registry?
(Simply Wall St.)
Mar-04-22 05:45PM
Bluebird Bio (BLUE) Reports Q4 Loss, Lags Revenue Estimates
(Zacks)
Jan-27-22 08:30AM
MeiraGTx Receives Clinical Development Milestone Payment from Janssen
(GlobeNewswire)
Jan-07-22 06:59AM
Recent 5.8% pullback isn't enough to hurt long-term MeiraGTx Holdings (NASDAQ:MGTX) shareholders, they're still up 106% over 3 years
(Simply Wall St.)
Dec-16-21 03:49PM
A Biotech Unveils Its New Gene Control Technology
(Barrons.com) -5.46%
Dec-14-21 04:30PM
MeiraGTx to Host a Virtual Research and Development Day on Gene Regulation
(GlobeNewswire)
Dec-07-21 07:00AM
MeiraGTx Announces Positive Preliminary Data from the AQUAx Phase 1 Clinical Trial of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
(GlobeNewswire) +17.83%
Nov-29-21 04:30PM
MeiraGTx to Provide a Xerostomia Clinical Program Update and Host a Virtual Research and Development Day on Gene Regulation
(GlobeNewswire)
Nov-10-21 09:25AM
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
(Zacks)
08:00AM
MeiraGTx Reports Third Quarter 2021 Financial and Operational Results
(GlobeNewswire)
Nov-09-21 04:30PM
MeiraGTx to Participate in Upcoming Virtual Investor Conferences
(GlobeNewswire)
Nov-08-21 09:29AM
MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans
(Simply Wall St.)
Oct-28-21 03:05PM
Earnings Preview: MeiraGTx Holdings PLC (MGTX) Q3 Earnings Expected to Decline
(Zacks)
Oct-19-21 08:30AM
MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress
(GlobeNewswire)
Oct-15-21 09:14PM
This Small Biotech Is Partnering With Johnson & Johnson. The Stock Could More Than Double.
(Barrons.com) +5.86%
08:00PM
This Small Biotech Could Have a Big Winner
(Barrons.com)
Oct-04-21 10:50AM
MeiraGTx Holdings plc (MGTX) Fell Out Of Favor With Hedge Funds
(Insider Monkey)
Sep-28-21 04:30PM
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
(GlobeNewswire)
Sep-14-21 10:24AM
5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal
(Zacks)
Sep-09-21 08:30AM
MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa
(GlobeNewswire)
Aug-12-21 01:46AM
Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
(Simply Wall St.)
Aug-11-21 09:25AM
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates
(Zacks)
08:00AM
MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
(GlobeNewswire)
Aug-09-21 06:31AM
Do Insiders Own Lots Of Shares In MeiraGTx Holdings plc (NASDAQ:MGTX)?
(Simply Wall St.)
Jul-29-21 03:05PM
MeiraGTx Holdings PLC (MGTX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
(Zacks)
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.